|

Human BCMA targeted CAR-NK cells injection Clinical Trials

1 actively recruiting trial

Also known as: BCMA CAR-NK

Pipeline

Early 1: 1

Top Sponsors

  • Hrain Biotechnology Co., Ltd.1

Indications

  • Plasma Cell Leukemia1
  • Multiple Myeloma1
  • Cancer1

Other1 trial

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.